First City Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-5,234
| Closed | -$201K | – | 153 |
|
|
2025
Q2 | $201K | Buy |
5,234
+10
| +0.2% | +$382 | 0.12% | 144 |
|
|
2025
Q1 | $202K | Buy |
+5,224
| New | +$191K | 0.12% | 144 |
|
|
2024
Q4 | – | Sell |
-7,488
| Closed | -$306K | – | 161 |
|
|
2024
Q3 | $306K | Sell |
7,488
-1,220
| -14% | -$49.9K | 0.16% | 130 |
|
|
2024
Q2 | $335K | Sell |
8,708
-1,991
| -19% | -$83.8K | 0.19% | 121 |
|
|
2024
Q1 | $459K | Sell |
10,699
-160
| -1% | -$6.6K | 0.25% | 99 |
|
|
2023
Q4 | $402K | Sell |
10,859
-6,475
| -37% | -$232K | 0.23% | 107 |
|
|
2023
Q3 | $628K | Sell |
17,334
-2,883
| -14% | -$102K | 0.39% | 71 |
|
|
2023
Q2 | $721K | Sell |
20,217
-4,460
| -18% | -$160K | 0.43% | 65 |
|
|
2023
Q1 | $889K | Buy |
24,677
+880
| +4% | +$30.8K | 0.52% | 52 |
|
|
2022
Q4 | $836K | Sell |
23,797
-1,756
| -7% | -$58.5K | 0.5% | 54 |
|
|
2022
Q3 | $752K | Buy |
25,553
+2,318
| +10% | +$87.9K | 0.5% | 57 |
|
|
2022
Q2 | $1.26M | Buy |
23,235
+800
| +4% | +$44.2K | 0.78% | 42 |
|
|
2022
Q1 | $1.22M | Buy |
22,435
+360
| +2% | +$19.6K | 0.67% | 45 |
|
|
2021
Q4 | $1.24M | Sell |
22,075
-920
| -4% | -$47.9K | 0.7% | 44 |
|
|
2021
Q3 | $1.1M | Sell |
22,995
-431
| -2% | -$21.6K | 0.62% | 49 |
|
|
2021
Q2 | $1.21M | Buy |
23,426
+373
| +2% | +$17.9K | 0.66% | 48 |
|
|
2021
Q1 | $1.1M | Buy |
23,053
+1,894
| +9% | +$86K | 0.64% | 50 |
|
|
2020
Q4 | $934K | Sell |
21,159
-26,856
| -56% | -$1.23M | 0.6% | 50 |
|
|
2020
Q3 | $2.23M | Buy |
48,015
+22,765
| +90% | +$1.14M | 0.83% | 40 |
|
|
2020
Q2 | $1.29M | Sell |
25,250
-700
| -3% | -$35.9K | 0.99% | 35 |
|
|
2020
Q1 | $1.23M | Sell |
25,950
-632
| -2% | -$33.7K | 1.2% | 31 |
|
|
2019
Q4 | $1.56M | Buy |
26,582
+127
| +0.5% | +$7.06K | 1.07% | 34 |
|
|
2019
Q3 | $1.41M | Sell |
26,455
-161
| -0.6% | -$8.28K | 1.03% | 36 |
|
|
2019
Q2 | $1.33M | Sell |
26,616
-566
| -2% | -$28.4K | 0.97% | 38 |
|
|
2019
Q1 | $1.42M | Sell |
27,182
-1,680
| -6% | -$83.9K | 1.02% | 33 |
|
|
2018
Q4 | $1.38M | Buy |
28,862
+46
| +0.2% | +$2.27K | 1.08% | 30 |
|
|
2018
Q3 | $1.45M | Buy |
28,816
+320
| +1% | +$16.3K | 0.96% | 38 |
|
|
2018
Q2 | $1.44M | Sell |
28,496
-40
| -0.1% | -$2.02K | 1.03% | 36 |
|
|
2018
Q1 | $1.39M | Hold |
28,536
| – | – | 1.04% | 37 |
|
|
2017
Q4 | $1.26M | Sell |
28,536
-288
| -1% | -$13.3K | 0.86% | 44 |
|
|
2017
Q3 | $1.46M | Buy |
28,824
+60
| +0.2% | +$3.04K | 1.02% | 32 |
|
|
2017
Q2 | $1.55M | Buy |
28,764
+40
| +0.1% | +$2.13K | 1.12% | 30 |
|
|
2017
Q1 | $1.51M | Sell |
28,724
-2,480
| -8% | -$126K | 1.12% | 30 |
|
|
2016
Q4 | $1.5M | Buy |
31,204
+1,567
| +5% | +$77.4K | 1.13% | 29 |
|
|
2016
Q3 | $1.6M | Buy |
29,637
+320
| +1% | +$17.5K | 1.22% | 23 |
|
|
2016
Q2 | $1.59M | Buy |
29,317
+940
| +3% | +$49.5K | 1.2% | 24 |
|
|
2016
Q1 | $1.44M | Sell |
28,377
-82
| -0.3% | -$4.08K | 0.98% | 25 |
|
|
2015
Q4 | $1.44M | Buy |
28,459
+2,625
| +10% | +$134K | 0.96% | 26 |
|
|
2015
Q3 | $1.24M | Buy |
25,834
+1,697
| +7% | +$88.3K | 0.91% | 29 |
|
|
2015
Q2 | $1.26M | Sell |
24,137
-560
| -2% | -$31.5K | 0.87% | 32 |
|
|
2015
Q1 | $1.42M | Buy |
24,697
+1,100
| +5% | +$63.1K | 0.99% | 25 |
|
|
2014
Q4 | $1.26M | Sell |
23,597
-60
| -0.3% | -$3.36K | 0.87% | 29 |
|
|
2014
Q3 | $1.36M | Sell |
23,657
-161
| -0.7% | -$9.87K | 0.97% | 26 |
|
|
2014
Q2 | $1.59M | Buy |
23,818
+6
| +0% | +$406 | 1.13% | 18 |
|
|
2014
Q1 | $1.59M | Sell |
23,812
-400
| -2% | -$27K | 1.14% | 18 |
|
|
2013
Q4 | $1.62M | Sell |
24,212
-906
| -4% | -$58.7K | 1.32% | 17 |
|
|
2013
Q3 | $1.58M | Buy |
25,118
+401
| +2% | +$25.8K | 1.3% | 17 |
|
|
2013
Q2 | $1.54M | Buy |
+24,717
| New | +$1.57M | 1.41% | 18 |
|
Other funds holding GSK
JEST
First City Capital Management's GSK Position: Q3 2025 in Review
First City Capital Management sold out of GSK (GSK) in Q3 2025, closing a stake of 5,234 shares — an estimated $201K sold.
First City Capital Management first reported a position in GSK in Q2 2013 and held it in 48 quarters. The position peaked at $2.23M in Q3 2020. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.
- First City Capital Management reported no remaining GSK position as of Q3 2025 after selling out during the quarter.
- First City Capital Management sold 5,234 GSK shares in Q3 2025, an estimated $201K.
- First City Capital Management first reported a position in GSK in Q2 2013 and held it in 48 quarters.
- First City Capital Management's GSK position peaked at $2.23M in Q3 2020.
- 895 funds tracked by Wall St. Rank held GSK as of Q3 2025.
Based on First City Capital Management's 13F filing for Q3 2025, filed 21 Oct 2025.